Teva Pharmaceuticals USA recalls Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx only, Manuf
Recalled February 9, 2022 · FDA recall D-0521-2022 · Teva Pharmaceuticals USA
Hazard
Mislabeling · FDA Class III
Units
218174 cartons
Sold at
USA Nationwide
Description
Mislabeling
Product
Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-28
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →